Adicet Bio, Inc. Operating Lease Liability
Adicet Bio, Inc. (ACET) had Operating Lease Liability of $12.06 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-05
- 2026-06-30: Operating Lease, Liability $12.06M.
- 2026-03-31: Operating Lease, Liability $12.91M.
- 2025-12-31: Operating Lease, Liability $13.75M.
- 2025-09-30: Operating Lease, Liability $14.57M.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2026-06-30 | $12.06M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $12.91M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $13.75M 10-K · filed 2026-03-12 | |
| 2025-09-30 | $14.57M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $15.36M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $16.25M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $17.20M 10-K · filed 2026-03-12 | $17.23M 10-K · filed 2025-03-06 |
| 2024-09-30 | $18.20M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $19.13M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $20.04M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $20.92M 10-K · filed 2024-03-19 | |
| 2023-09-30 | $21.80M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $22.64M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $23.50M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $21.02M 10-K · filed 2023-03-15 | |
| 2022-09-30 | $21.72M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $22.39M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $20.58M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $20.94M 10-K · filed 2022-03-15 | |
| 2021-09-30 | $20.54M 10-Q · filed 2021-11-10 | |
| 2020-12-31 | $21.64M 10-K · filed 2021-03-12 | |
| 2020-01-01 | $1.80M 10-K · filed 2021-03-12 | |
| 2018-10-31 | $1.30M 10-K · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |